Chinese pharma research services company selects Watson LIMS

WuXi PharmaTech, a leading Chinese pharmaceutical r&d services company, has selected Thermo Electron Corporation's Watson LIMS to meet the specific data management requirements of its bioanalytical facilities.

Shanghai-based WuXi PharmaTech serves 19 of the top 20 pharmaceutical companies and 8 of the top 10 biopharmaceutical companies in the world with discovery and development services, from lead identification to pre-clinical, at its state-of-the-art facilities.

"This agreement to deploy Watson LIMS catapults our bioanalytical service group to the globally accepted quality level," said Dr. Ge Li, chaiman and ceo of WuXi PharmaTech. "Using Thermo LIMS will significantly accelerate our analysis and laboratory turn-around, reduce costs associated with sample management, and increase workflow efficiency."

Watson, part of Thermo's pharmaceutical suite of informatics solutions, is a leading laboratory information management system (LIMS) for bioanalytical labs. As a purpose-built, commercial-off-the-shelf solution, Watson promotes compliance with Good Laboratory Practices (GLP) regulations and 21 CFR Part 11 guidance from the US FDA. It is used by 18 of the top 20 global pharmaceutical organisations, and in leading biotechnology and contract research organisations worldwide.